Eliana Clark, EVP, Chief Technical Officer at Intellia Therapeutics, Inc. (NTLA), sold 5,000 shares at $45.00 ($225K) on 2023-06-20, disclosed to the SEC on 2023-06-22.
Scheduled sale ($225k) by EVP, Chief Technical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| Filing → |
| NTLA | SELL | 2025-07-03 | $10K | — | Filing → |
| NTLA | SELL | 2025-03-04 | $6K | — | Filing → |
| NTLA | SELL | 2025-01-06 | $187K | — | Filing → |